ASLTY (Asymchem Laboratories Tianjin Co) EBIT: $180.8 Mil (TTM As of Mar. 2026)


ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
72 GF Score
Price $6.37
GF Value $4.52
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co EBIT?

Asymchem Laboratories Tianjin Co ASLTY 72 EBIT is $180.8 Mil as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 72/100 and a GF Value™ of $4.52 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Asymchem Laboratories Tianjin Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $48.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $180.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Asymchem Laboratories Tianjin Co's annualized ROC % for the quarter that ended in Mar. 2026 was 13.11%. Asymchem Laboratories Tianjin Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 15.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Asymchem Laboratories Tianjin Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.18%.


Asymchem Laboratories Tianjin Co  (OTCPK:ASLTY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Asymchem Laboratories Tianjin Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=234.4 * ( 1 - 9.66% )/( (1588.126 + 1642.918)/ 2 )
=211.75696/1615.522
=13.11 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2879.013 - 234.899 - ( 1055.988 - max(0, 279.488 - 1633.68+1055.988))
=1588.126

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3004.157 - 232.665 - ( 1128.574 - max(0, 298.983 - 1702.072+1128.574))
=1642.918

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Asymchem Laboratories Tianjin Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=195.204/( ( (936.521 + max(285.913, 0)) + (985.831 + max(263.189, 0)) )/ 2 )
=195.204/( ( 1222.434 + 1249.02 )/ 2 )
=195.204/1235.727
=15.80 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(276.298 + 208.837 + 72.782) - (234.899 + 0 + 37.105)
=285.913

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(267.66 + 235.154 + 51.508) - (232.665 + 0 + 58.468)
=263.189

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Asymchem Laboratories Tianjin Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=180.843/3493.057
=5.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co EBIT Related Terms


Asymchem Laboratories Tianjin Co EBIT Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co EBIT Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.45 535.81 358.96 148.60 184.45

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.68 48.22 29.90 53.92 48.80

ASLTY vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's EV-to-EBIT falls into.


ASLTY
72GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $180.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $180.8 Mil mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a EBIT of $180.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Asymchem Laboratories Tianjin Co.
Is Asymchem Laboratories Tianjin Co's EBIT too high?
Asymchem Laboratories Tianjin Co's current EBIT is $180.8 Mil. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's EBIT compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's EBIT of $180.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Asymchem Laboratories Tianjin Co. Asymchem Laboratories Tianjin Co's current EBIT is $180.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $6.37 — trading 40.9% above its estimated fair value. The current EBIT is $180.8 Mil. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current EBIT is $180.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 40.9% above its estimated GF Value™ of $4.52. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • EBIT: $180.8 Mil
  • GF Value™: $4.52 vs. price of $6.37 (40.9% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score

Get the complete analysis for ASLTY

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$4.52
GF Value